Obesity-associated intestinal insulin resistance is ameliorated after bariatric surgery

Diabetologia

Volumn 58, Issue 5, 2015, Pages 1055-1062

  Mäkinen, Jaakko ^a   Hannukainen, Jarna C ^a   Karmi, Anna ^a   Immonen, Heidi M ^a,b   Soinio, Minna ^b   Nelimarkka, Lassi ^b   Savisto, Nina ^a   Helmiö, Mika ^b   Ovaska, Jari ^b   Salminen, Paulina ^b   Iozzo, Patricia ^c   Nuutila, Pirjo ^a,b  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Bariatric surgery; Insulin resistance; Intestine; Obesity; Positron emission tomography; Type 2 diabetes

Indexed keywords

GLUCOSE BLOOD LEVEL;

ADULT; BARIATRIC SURGERY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; INTESTINE; MALE; METABOLISM; MIDDLE AGED; OBESITY, MORBID; PHYSIOLOGY; SKELETAL MUSCLE; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; BARIATRIC SURGERY; BLOOD GLUCOSE; FEMALE; HUMANS; INSULIN RESISTANCE; INTESTINES; MALE; MIDDLE AGED; MUSCLE, SKELETAL; OBESITY, MORBID; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84939933295     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-015-3501-3     Document Type: Article

References (23)

1. Rubino F, Schauer PR, Kaplan LM, Cummings DE (2010) Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med 61:393–411
2. Helmio M, Victorzon M, Ovaska J et al (2012) SLEEVEPASS: a randomized prospective multicenter study comparing laparoscopic sleeve gastrectomy and gastric bypass in the treatment of morbid obesity: preliminary results. Surg Endosc 26:2521–2526
3. Meijer RI, van Wagensveld BA, Siegert CE, Eringa EC, Serne EH, Smulders YM (2011) Bariatric surgery as a novel treatment for type 2 diabetes mellitus: a systematic review. Arch Surg 146:744–750
4. Bradley WD, Zwingelstein C, Rondinone CM (2011) The emerging role of the intestine in metabolic diseases. Arch Physiol Biochem 117:165–176
5. Andreelli F, Amouyal C, Magnan C, Mithieux G (2009) What can bariatric surgery teach us about the pathophysiology of type 2 diabetes? Diabetes Metab 35:499–507
6. Nannipieri M, Mari A, Anselmino M et al (2011) The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery. J Clin Endocrinol Metab 96:E1372–E1379
7. Mingrone G, Castagneto-Gissey L (2009) Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery. Diabetes Metab 35:518–523
8. Dirksen C, Jorgensen NB, Bojsen-Moller KN et al (2012) Mechanisms of improved glycaemic control after roux-en-Y gastric bypass. Diabetologia 55:1890–1901
9. Iozzo P, Jarvisalo MJ, Kiss J et al (2007) Quantification of liver glucose metabolism by positron emission tomography: validation study in pigs. Gastroenterology 132:531–542
10. Peltoniemi P, Lonnroth P, Laine H et al (2000) Lumped constant for [(18)F]fluorodeoxyglucose in skeletal muscles of obese and nonobese humans. Am J Physiol Endocrinol Metab 279:E1122–E1130
11. Hasselbalch SG, Holm S, Pedersen HS et al (2001) The (18)F-fluorodeoxyglucose lumped constant determined in human brain from extraction fractions of (18)F-fluorodeoxyglucose and glucose. J Cereb Blood Flow Metab 21:995–1002
12. 18F]fluorodeoxyglucose and positron emission tomography (PET) for the measurement of intestinal metabolism in pigs, and evidence of intestinal insulin resistance in patients with morbid obesity. Diabetologia 56:893–900
13. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26(Suppl 1):S5–20
14. DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214–E223
15. Nuutila P, Koivisto VA, Knuuti J et al (1992) Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. J Clin Invest 89:1767–1774
16. 18F]-fluoro-2-deoxy-d-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 27:235–238
17. DeGrado TR, Turkington TG, Williams JJ, Stearns CW, Hoffman JM, Coleman RE (1994) Performance characteristics of a whole-body PET scanner. J Nucl Med 35:1398–1406
18. Patlak CS, Blasberg RG (1985) Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data generalizations. J Cereb Blood Flow Metab 5:584–590
19. Ait-Omar A, Monteiro-Sepulveda M, Poitou C et al (2011) GLUT2 accumulation in enterocyte apical and intracellular membranes: a study in morbidly obese human subjects and ob/ob and high fat-fed mice. Diabetes 60:2598–2607
20. Dyer J, Wood IS, Palejwala A, Ellis A, Shirazi-Beechey SP (2002) Expression of monosaccharide transporters in intestine of diabetic humans. Am J Physiol Gastrointest Liver Physiol 282:G241–G248
21. Tobin V, Le Gall M, Fioramonti X et al (2008) Insulin internalizes GLUT2 in the enterocytes of healthy but not insulin-resistant mice. Diabetes 57:555–562
22. Mithieux G (2012) A synergy between incretin effect and intestinal gluconeogenesis accounting for the rapid metabolic benefits of gastric bypass surgery. Curr Diab Rep 12:167–171
23. Mithieux G (2012) Comment about intestinal gluconeogenesis after gastric bypass in human in relation with the paper by Hayes et al., Obes. Surg. 2011. Obes Surg 22:1920–1922